Inhibition of ceramide kinase is effectively against cisplatin-resistant ovarian cancer cells by regulating ceramide and C1P levels

Conclusions: Our work is the first to show the critical role of CerK as the underlying mechanism of ovarian cancer chemoresistance, through regulating ceramide and C1P.
Source: Gynecologic and Obstetric Investigation - Category: OBGYN Source Type: research